Farnesyltransferase Inhibitors Are Potent Lung Cancer Chemopreventive Agents in a/J Mice With a Dominant-Negative P53 and/or Heterozygous Deletion of Ink4a/Arf
Oncogene- United Kingdom
doi 10.1038/sj.onc.1206630
Full Text
Abstract
Available in
Date
September 1, 2003
Authors
Publisher
Springer Science and Business Media LLC